Clinical Trial Update: Lasix for the Prevention of De Novo Postpartum Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Lasix (furosemide) for prevention of de novo postpartum hypertension has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Hypertension
• Hypertension Pregnancy-induced
• Postpartum Hypertension
• Postpartum Preeclampsia
• Preeclampsia

Drugs mentioned

• Lasix (furosemide)

Snippet

Sponsor: Columbia University | Conditions: Postpartum Pregnancy-Induced Hypertension, Postpartum Preeclampsia | Phase 3 | Status: COMPLETED | Results posted: 2023-05-11